Citation: Rs. Dir et Sc. Zell, ANALYSIS OF THE INCREMENTAL COST ASSOCIATED WITH HIV THERAPEUTICS IN THE ERA OF HIGHLY-ACTIVE ANTIRETROVIRAL TREATMENT, Journal of investigative medicine, 46(1), 1998, pp. 88-88
Citation: Rs. Dir et Sc. Zell, TRIPLE-DRUG THERAPY VERSUS SELECT USE OF DUAL NUCLEOSIDE ANALOGS AS FRONT-LINE ANTIRETROVIRAL TREATMENT - A COST COMPARISON, Journal of investigative medicine, 46(1), 1998, pp. 100-100